Point72 Hong Kong LTD Akero Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $14,752 - $27,678	-1,844 Reduced 82.25%	398 $4,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $29,078 - $49,906	2,242 New	2,242 $32,000
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $12,915 - $17,056	-650 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $38,661 - $52,778	-2,073 Reduced 76.13%	650 $15,000
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $61,131 - $79,710	2,464 Added 951.35%	2,723 $68,000
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $8,077 - $11,487	-336 Reduced 56.47%	259 $8,000
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $728 - $866	29 Added 5.12%	595 $15,000
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $6,219 - $8,063	202 Added 55.49%	566 $17,000
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $6,429 - $8,937	334 Added 1113.33%	364 $9,000
Q1 2020 May 15, 2020	SELL	$12.8 - $27.05 $3,865 - $8,169	-302 Reduced 90.96%	30 $1,000
Q4 2019 Feb 14, 2020	BUY	$17.37 - $27.27 $5,766 - $9,053	332 New	332 $7,000
Q3 2019 Nov 14, 2019	SELL	$16.89 - $29.88 $67,695 - $119,759	-4,008 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.08 - $19.83 $72,464 - $79,478	4,008 New	4,008 $77,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.42B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.